NEW YORK (Reuters) - Vivus Inc's largest shareholder on Tuesday took the unusual step of naming the man it would install as the drugmaker's chief executive should it prevail in its battle to gain control of the board of directors this month.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/ZG6qOiKFMHI/story01.htm
phlebotomy classes in utah phlebotomy technician schools phlebotomy schools in louisiana
No comments:
Post a Comment